Budesonide
Brand name: Budesonide Dr
Rank #327 of 500 drugs by total cost
$33.1M
Total Cost
120,202
Total Claims
$33.1M
Total Cost
5,914
Prescribers
$275
Cost per Claim
9,869
Beneficiaries
155,905
30-Day Fills
$5,598
Avg Cost/Provider
20
Avg Claims/Provider
About Budesonide
Budesonide (sold as Budesonide Dr) was prescribed 120,202 times by 5,914 Medicare Part D providers in 2023, costing the program $33.1M. At $275 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
| 325 | Dorzolamide Hcl/Timolol Maleat (Dorzolamide-Timolol) | $33.5M | 1,096,480 |
| 326 | Morphine Sulfate (Morphine Sulfate Er) | $33.2M | 1,023,056 |
| 327 | Budesonide (Budesonide Dr) | $33.1M | 120,202 |
| 328 | Mavacamten (Camzyos) | $32.8M | 3,969 |
| 329 | Empagliflozin/Linagliptin (Glyxambi) | $32.6M | 34,331 |
| 330 | Methotrexate Sodium (Methotrexate) | $32.4M | 911,965 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology